What is already known about this subject?
There is a substantial literature describing the performance of different variables derived from cardiopulmonary exercise testing (CPET) as predictors of prognosis. Optimal cut-points delineating higher risk patients are often identified using binary statistical approaches.
However, the traditional approach often focuses on the top performing variable(s) whilst discounting the additive or cumulative effect of a combination of different predictor variables. Composite risk scores, which combine the level of risk across a number of variables, have become increasingly prevalent especially in studies including patients with heart failure (HF).
What does this study add?
None of the composite approaches to risk scores derived by CPET have combined both conventional variables, such as peak VO 2 and VE/VCO 2 slope, and more recently described variables, such as the presence of exertional oscillatory ventilation, VEqCO 2 nadir, peak circulatory power and oxygen uptake efficiency slope. We have developed a composite risk model derived from CPET-related variables (traditional and contemporary) to predict mortality in patients with mild-to-moderate HF. Our model derived from CPET-only variables outperformed the Heart Failure Survival Score.
How might this impact on clinical practice?
Clinicians should consider using composite risk scores from CPET studies to improve risk prediction in patients with mild-to-moderate heart failure. Chronic heart failure (HF) is very common and has a poor prognosis despite medical therapy.
(1) The patient's performance during a cardio-pulmonary exercise test (CPET) is used to assess prognosis and to help select patients who might benefit from heart transplantation. CPET broadly provides two types of prognostic variable: a measure of exercise capacity, such as peak oxygen consumption (VO 2 ) or peak circulatory power (markers of oxygen delivery and extraction), and a measure of the ventilatory response to exercise, such as the slope of the relation between ventilation and carbon dioxide production (VE/VCO 2 slope), reflecting the abnormal stimulus to ventilation in HF. (2) There is a large literature describing the performance of different variables derived from CPET as predictors of prognosis. Optimal cut-points delineating higher risk patients are often identified using binary statistical approaches. However, the traditional approach often focuses on the top performing variable(s) whilst discounting the additive or cumulative effect of a combination of different predictor variables. To develop the composite risk score, we focused on variables that have previously been identified as independent predictors of mortality in patients with HF:
• Exercise oscillatory ventilation (EOV) during CPET using the criteria described by
Leite and colleagues. • Peak oxygen uptake (peak VO 2 ) was calculated as the average VO 2 for the final 30s of exercise.
• Peak circulatory power (PCP) was defined as the product of peak VO 2 and peak systolic arterial pressure at peak exercise intensity.(9)
• The oxygen uptake efficiency slope (OUES) was derived from the linear relationship between oxygen consumption (VO 2 ) and log 10 ventilation (VE). (10) • The ventilatory anaerobic threshold (AT) was calculated by the V-slope method. (11) • The gradient of the relationship between VE and VCO 2 (VE/VCO 2 slope) was calculated by linear regression analysis using data acquired from the whole test.
• The lowest point of the relation between ventilation and carbon dioxide production • Heart rate reserve (HRR) was calculated as the difference between resting heart rate and peak heart rate achieved during the CPET.
Statistical Methodology
Continuous data are summarised by the median (25 th to 75th percentile ranges); categorical data by percentages. The primary outcome measure was all-cause mortality. Models were built and validated using a hybrid approach between the bootstrap and Cox regression. (14) We have used the method in previous work. (15) Bootstrapping is sampling data with replacement meaning that an individual may be selected more than once per bootstrapped sample. (16) There should be no more than 200 bootstraps per sample,(17) and the method is not without its critics.(18) However, Sauerbrei (14) contended that with respect to bootstrap sampling, key variables will be included in most replications, and the inclusion frequency may be used as a criterion for the importance of a variable. To test the adequacy of the model we generated 10 test samples using 10-fold cross-validation. The data was split into 10 equal subsamples (S1-S10) at random. From this we generated 10 test samples leaving out 10% of the data at a time. Thus, test sample 1 was generated leaving out sub-sample S1 and so on.
Royston (19) recently developed a new measure of explained variance for use with censored survival data which was applied to the test samples.
Nine CPET-derived variables were included: EOV, OUES, VEqCO 2 nadir, VE/VCO 2 slope, resting PETCO 2 , peak VO 2 , HRR, AT, and PCP. Optimal binary cut-points were calculated from receiver operating characteristic (ROC) curves. The cut-offs were determined by maximising Goodness-of-fit was explored by Cox-Snell residuals. We fitted a multivariable Cox regression model on the nine variables. We expressed each variable's predictive strength by its Z-score (model coefficient/standard error). Model coefficients were converted to a risk score by multiplying by 10 (for ease of rounding) and summing over all patients. (21) The proportionality of hazards (PH) assumption was based on the global PH test. (22) Prognostic comparisons between models were made by Harrell's concordance c-statistic, a summary measure of model accuracy (23) 
External validation
We validated our CPET risk score against the more established Heart Failure Survival Score (HFSS). (26) The HFSS uses seven variables that independently predict prognosis: peak oxygen uptake, resting heart rate (HR), mean blood pressure (mBP), LVEF, serum sodium, presence/absence of ischaemic heart disease, presence/absence of an intraventricular defect (IVCD). The presence of IVCD was defined as QRS interval ≥120 msec due to left or right bundle branch block or ventricular-paced rhythm (irrespective of CRT). (27) Table 3 shows the distribution of our risk score for all patients and includes observed and expected deaths (under the assumption of no relationship between survival and risk score).
For a risk score of 29 points, there was an excess of deaths in a ratio of 3.8:1. Table 4 shows the consistency of the optimal model (EOV + OUES + VEqCO 2 nadir + VE/VCO 2 slope) when 10 random samples of 90% of the distribution were re-tested. The number of events in the test samples ranged from 90-104. Explained variance for each random model was similar (range 43%-53%) demonstrating good consistency in the overall model. Table 5 shows changes in explained variance for CPET variables when presented as single variables, or in two-way or three-way combinations. Explained variance in single CPET variables ranged from 12% -26%;
variance increased when CPET variables were considered in two-way combinations (30%-37%);
and was highest when variables were presented in three-way combinations (36%-43%). For example, EOV + VEqCO 2 nadir + OUES demonstrated an explained variance of 43% (29-55%).
This analysis provides further supporting evidence for our 4-variable risk score. Figure 1 shows a Kaplan-Meier curve: as the risk score increases, so does the probability of death (log-rank test=109.2, df=3, P<0.001).
We explored the goodness-of-fit of our CPET risk score by plotting Cox-Snell residuals against the 45 o line, and found that the residual plot was closely related (Figure 2 ). The HR for our risk score was 1.10 (95% CI=1.08-1.10; AUC: 0.78; P<0.001). The Hull CPET risk score had a significantly higher area under the curve (0.78) when compared to the Heart Failure Survival Score (AUC=0.70; P<0.001; Figure 3 ). We have shown that a composite risk score using variables from CPET out-performs the traditional single variable approach in predicting outcome in patients with mild-to-moderate HF. We validated our model against the Heart Failure Survival Score (26) and found that variables collected solely from CPET significantly outperformed the well established HFSS.
The HFSS includes only one CPET-related variable, peak oxygen uptake. The other six variables are derived from a combination of standard investigative methods including echocardiography, electrocardiography, blood pressure monitoring, blood biochemistry, and patient history (aetiology of disease). Recently, Goda and colleagues (27) showed that the HFSS outperformed peak oxygen uptake alone for stratifying risk in CHF patients in the presence of implantable cardioverter-defibrillators and/or cardiac resynchronisation therapy. Risk stratification models should investigate the efficacy of combinations of CPETrelated variables in the era of device therapy.
Historically, most exercise-related composite risk scores have been developed in patients with coronary artery disease prior to the widespread adoption of CPET.(5) Perhaps the most accepted integrated exercise risk score is the Duke Treadmill Score (DTS) which has both prognostic (30) and diagnostic (31) predictive power. The DTS combines exercise time (using a Bruce protocol) with ECG abnormalities (ST segment depression) and symptoms of angina.
It was originally described in patients with coronary artery disease, though successful validation in other sub-groups has been reported.(32) Few composite risk score have been developed which have specifically included CPET variables for risk stratification among HF patients. The models were prospectively validated on 199 similar patients, and the non-invasive model performed well in both samples, and model performance did not improve with the addition of invasive catheterisation-related data. The authors concluded that the selection of candidates for cardiac transplantation may be improved by using a non-invasive riskstratification model which included peak VO 2 . Myers and colleagues (3) recruited 710 patients with HF (80% male; 56 ± 13 years; LVEF 33 ± 13 %) from four different institutions in Italy and the USA. CPET-derived variables included in the risk score included peak VO 2 , VE/VCO 2 slope, OUES, resting PETCO 2 , heart rate recovery and chronotropic index. The VE/VCO 2 slope (optimal cut point ≥34) was the strongest predictor of risk and attributed a relative weight of 7 points. A cumulative CPET score >15 points was associated with an annual mortality of 27% and a relative risk of 7.6. The authors recently published a validation study (34) of their original work in a larger sample size using a different statistical approach. Our study extends these findings by including other independent predictors of mortality in our risk algorithm such as ventilatory variables, EOV and VEqCO 2 nadir, and circulatory-related variables including heart rate reserve and peak circulatory power.
Guazzi and co-workers (5) used peak VO 2 , VE/VCO 2 slope, EOV, to develop a prognostic risk score in 695 patients with heart failure. EOV was the strongest single predictor of cardiac mortality. The greatest contribution to the risk score was provided by EOV, followed by VE/VCO 2 slope, whereas peak VO 2 added minimal prognostic value. However, one of the major limitations of the study was that it only included 3 variables and did not include other potentially important predictive variables such as OUES, VEqCO 2 nadir, and peak circulatory 
Conclusion
We have found that a composite risk score using four CPET-derived variables (EOV + VE/VCO 2 slope + OUES + VEqCO 2 nadir) out-performs the traditional single variable approach in predicting outcome in patients with mild-to-moderate HF.
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